Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Dow
Mallinckrodt
Fish and Richardson
Chubb
Teva
Boehringer Ingelheim
Healthtrust
Colorcon

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,646,180

« Back to Dashboard

Summary for Patent: 5,646,180
Title: Treatment of the CNS effects of HIV
Abstract:Methods and compositions for treating the central nervous system (CNS) effects of HIV, particularly AIDS related dementia.
Inventor(s): Chaturvedi; Pravin Ramsewak (Quincy, MA)
Assignee: Vertex Pharmaceuticals Incorporated (Cambridge, MA)
Application Number:08/567,199
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,646,180

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,646,180

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 722850 ➤ Try a Free Trial
Australia 1148697 ➤ Try a Free Trial
Brazil 9611861 ➤ Try a Free Trial
Canada 2238471 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKinsey
US Department of Justice
Fish and Richardson
Chinese Patent Office
Covington
Accenture
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.